Structure Therapeutics Inc. American Depositary Shares (GPCR)
PHARMACEUTICAL PREPARATIONS
- Headquarters
- United States
- Employees
- 233
- Market Cap
- $3.5B
About Structure Therapeutics Inc. American Depositary Shares
Structure Therapeutics Inc is a clinical-stage biopharmaceutical company developing novel oral small-molecule therapeutics to treat a wide range of chronic diseases with unmet medical needs. Its differentiated technology platform leverages both structure-based drug discovery and expertise in computational chemistry to discover and develop small molecule therapeutics against G-protein coupled receptors (GPCRs). The group operates and manages its business as one reportable and operating segment, which is the business of research and development of medicines that target chronic diseases with unmet medical needs.
SentiSense also tracks daily options readings for Structure Therapeutics Inc. American Depositary Shares: IV rank, put/call percentile, 25-delta skew, open-interest walls, and unusually active contracts, each measured against the stock's own history. Sign in to view them.
Structure Therapeutics Inc. American Depositary Shares stock analysis, sentiment tracking, and market intelligence on SentiSense.